These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31286752)

  • 1. Molecular imaging of bone metastases using bone targeted tracers.
    Vaz S; Usmani S; Gnanasegaran G; Van den Wyngaert T
    Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):112-128. PubMed ID: 31286752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of bone metastases using tumor-targeted tracers.
    Karamzade-Ziarati N; Manafi-Farid R; Ataeinia B; Langsteger W; Pirich C; Mottaghy FM; Beheshti M
    Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):136-149. PubMed ID: 31315347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
    Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging of Bone Metastases and Their Response to Therapy.
    Cook GJR; Goh V
    J Nucl Med; 2020 Jun; 61(6):799-806. PubMed ID: 32245899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.
    Kulshrestha RK; Vinjamuri S; England A; Nightingale J; Hogg P
    J Nucl Med Technol; 2016 Dec; 44(4):217-222. PubMed ID: 27634981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
    Woodhead GJ; Avery RJ; Kuo PH
    Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
    Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
    Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT.
    Gnanasegaran G; Cook G; Adamson K; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):380-95. PubMed ID: 19801218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer.
    Iagaru A; Minamimoto R
    PET Clin; 2018 Jul; 13(3):383-393. PubMed ID: 30100077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.
    Broski SM; Young JR; Kendi AT; Subramaniam RM
    PET Clin; 2019 Jan; 14(1):103-120. PubMed ID: 30420213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer: role of SPECT and PET in imaging bone metastases.
    Ben-Haim S; Israel O
    Semin Nucl Med; 2009 Nov; 39(6):408-15. PubMed ID: 19801220
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Langsteger W; Rezaee A; Pirich C; Beheshti M
    Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of positron emission tomography in the management of bone metastases.
    Cook GJ; Fogelman I
    Cancer; 2000 Jun; 88(12 Suppl):2927-33. PubMed ID: 10898336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.